$16.51
0.030.18%
At close: Nov 11, 4:00 PM EST
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc.
ALPMYOTCPK
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma rose 37.7% from $11.97 to $16.48, ahead of the S&P 500's +12.7%. Its worst day was Mar 2 (−5.3%), and its low came Nov 13 at $11.97.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma shares rose 8.9%, while the S&P 500 fell 0.5%.
+8.9%, the year's best day · S&P 500 −0.5%
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma shares fell 5.3%, while the S&P 500 rose 0.1%.
Story events cover the past 12 months · Times ET
−5.3%, the year's worst day · S&P 500 +0.1%
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma closed at its highest level of the year, 40.2% above where the year started.
+3.5% · S&P 500 +0.8%
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma shares rose 5.6%, while the S&P 500 rose 0.2%.
+5.6% · S&P 500 +0.2%
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma shares fell 4.8%, while the S&P 500 rose 0.7%.
−4.8% · S&P 500 +0.7%
ASTELLAS PHARMA UNSP/ADR by Astellas Pharma shares rose 4.8%, while the S&P 500 rose 0.2%.
+4.8% · S&P 500 +0.2%
Where it ended: a close of $16.48 on Nov 11, 2026.
Nothing in the past 12 months.
All ALPMY earningsNothing in the past 12 months.
All ALPMY analyst actionsNothing in the past 12 months.
All ALPMY dividend historyNothing in the past 12 months.
All ALPMY news
